Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Ltd ADR (NY: TEVA )

8.830 +0.600 (+7.29%)
Official Closing Price Updated: 7:00 PM EDT, Oct 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,268,354
Open 8.400
Bid (Size) 8.790 (1)
Ask (Size) 8.870 (1)
Prev. Close 8.230
Today's Range 8.380 - 8.830
52wk Range 6.779 - 11.34
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Teva Reaches Agreement With Georgia to Settle the State’s Price Fixing Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
European Drug Makers Say Higher Energy Costs Eating Margins: Report
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs. 
Via Benzinga

Performance

YTD
+6.00%
+6.00%
1 Month
+1.03%
+1.03%
3 Month
+14.53%
+14.53%
6 Month
-10.72%
-10.72%
1 Year
-8.21%
-8.21%

More News

Read More
Teva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, Inspiration and Resources on HD Chorea
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Via Benzinga
Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression
Via Benzinga
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
Via Benzinga
Top Financial Media Stories Monday, September 19: Apple iPhone 14's Glitch With Some Third Party Apps, Tesla Wants To Double Sales In Germany, Ford Working On Smartphone Based Crash Detection Tech And More..
Via Benzinga
Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression
From Teva Pharmaceutical Industries Limited
Via Business Wire
CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma Management
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respiratory Society (ERS) International Congress 2022
From Teva Pharmaceutical Industries Limited
Via Business Wire
European Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countries
From Teva Pharmaceutical Industries Limited
Via Business Wire
Is Sanofi A Buy, Despite Recent Stumbles?
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Volume Surges Spark Turnarounds for These 3 Stocks
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Via Benzinga
Synaptics To $205? Plus Stifel Cuts Twilio's PT From $200 To This Level
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Via Benzinga
Cramer Says This Stock Is Losing Money As 'Too Many Companies Doing The Same Thing'
Via Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
Via InvestorPlace
Allergan To End Around 3,000 Opioid Lawsuits With Over $2B In Settlement: Report
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.